Action A243070 HUONS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Huons Co., Ltd.

Actions

A243070

KR7243070000

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 03/05/2024 		Varia. 5j. Varia. 1 janv.
34 950 KRW +0,58% Graphique intraday de Huons Co., Ltd. +1,75% -8,98%
20/03 Huons Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Huons Co. annonce ses résultats pour l'exercice clos le 31 décembre 2022 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
South Korea's Huons to Export Anesthetics to Canada
GenEdit Inc. amended terms of the transaction
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
GenEdit Inc. announced that it expects to receive $30 million in funding
Haemato : to Seek EU Approval for Botox Product
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A243070
  4. Actualités Huons Co., Ltd.
  5. Autres langues